Blanchard-Eric-25602-web

Eric Blanchard

Partner
eblanchard@cooley.com
Full contact info

About Eric

Eric practices corporate and securities law. He counsels domestic and foreign public and private companies, with an emphasis on those in the technology and biopharma industries, as well as investment banks. Eric advises clients on a variety of corporate transactions, including initial public offerings (IPOs), follow-on equity offerings, pre-IPO financings, investment-grade, high-yield and convertible debt offerings, liability management transactions, proxy contests and acquisitions. He also represents public companies with respect to securities and disclosure issues and corporate governance matters.

View full bio

Experience

Lexeo Therapeutics Announces $100 Million IPO

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, New York
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Zimu Yang
Associate, Washington DC
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

Capital Markets
Life Sciences
Biotechnology
Emerging Companies
Public Companies
Healthcare
Employment & Labor
Tax
Intellectual Property
CFIUS
Compensation & Benefits
Commercial Litigation

ImmuneOnco Biopharmaceuticals – HK$319 Million IPO

ImmuneOnco Biopharmaceuticals – HK$319 Million IPO

September 5, 2023

Cooley advised ImmuneOnco Biopharmaceuticals, a clinical-stage biotechnology company dedicated to the development of immuno-oncology therapies, on its HK$319 million initial public offering.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado
Eric Blanchard
Partner, New York
Yiying Wang
Associate, Shanghai
Kaiting Yang
Associate, Hong Kong
Yunxiang Xu
Associate, Shanghai
Xiaoyu Xu
Associate, Beijing
Cecilia Bai
Associate , Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Cindy Pan
International Legal Project Manager, Hong Kong
Alex Wu
International Legal Project Manager, Shanghai
Iris Yang
Senior Legal Assistant, Shanghai
Zhengyang Li
Senior Legal Assistant, Hong Kong

Related Practices & Industries

Capital Markets
Life Sciences
Biotechnology
Asia
Tax

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

NewAmsterdam Pharma – $181.6 Million Follow-on Offering

June 6, 2023

Cooley advised the underwriters in NewAmsterdam Pharma’s $181.6 million follow-on offering. NewAmsterdam is a clinical-stage biopharmaceutical company with a mission to improve care of patients with metabolic diseases where currently approved therapies have not been sufficiently successful or well tolerated. Lawyers Eric Blanchard, Div Gupta, Jean Park, Minkyu Park, Charles York, and Katie Lapidus led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Div Gupta
Partner, New York
Jean Park
Partner, New York
Minkyu Park
Associate, New York
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC

Related Practices & Industries

Capital Markets
Life Sciences

Olink Holding AB – $116.6 Million Follow-on Offering

Olink Holding AB – $116.6 Million Follow-on Offering

January 18, 2023

Cooley advised the underwriters in Olink Holding AB’s $116.6 million follow-on offering. Olink is a company dedicated to working with the scientific community on accelerating proteomics across multiple disease areas to enable new discoveries and improve the lives of patients. Lawyers Eric Blanchard, Charlie Kim, Minkyu Park, Ryan Walker, Katie Lapidus, Megan Taing and Charles York led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Charlie Kim
Partner, San Diego
Minkyu Park
Associate, New York
Katie Lapidus
Associate, Washington DC
Charles York
Associate, New York

Related Practices & Industries

Capital Markets
Life Sciences

Zoetis – $1.35 Billion Investment Grade Bond Offering

Zoetis – $1.35 Billion Investment Grade Bond Offering

November 8, 2022

Cooley advised Zoetis on its $1.35 billion aggregate principal amount of investment-grade unsecured senior notes, $600 million of 5.400% senior notes due 2025, and $750 million of 5.600% senior notes due 2032. Zoetis is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. Eric Blanchard and Madison Jones led the Cooley team.

Related contacts

Eric Blanchard
Partner, New York
Madison Jones
Partner, Washington DC
Katherine Denby
Associate, Washington DC
Olivia Creser
Associate, New York

Related Practices & Industries

Capital Markets
View more

Rankings & accolades

Chambers USA: Capital Markets: Debt & Equity: Eastern United States – Nationwide (2020 – 2023)

Chambers Global: Capital Markets: Debt & Equity: Eastern United States

IFLR1000: Notable Practitioner in Capital Markets: Debt, Equity and High Yield 

Who’s Who Legal: Global Leader in Capital Markets – Debt & Equity

The Legal 500 US: Key Lawyer in Capital Markets: Equity Offerings 

 

He has been absolutely brilliant. He is relaxed, measured, on top of all the issues and a delight to deal with.

Client Testimonial, Chambers USA